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Shock Index as Simple Clinical Independent Predictor of 
In-hospital MACEs in NSTEMI Patients 
Presenting with Heart Failure
Ahmad Handayani, Kartika Kaban, Marwan Nasri, Zulfikri Mukhtar, Abdullah Afif Siregar
Background: Identification of Non-ST Elevation Myocardial Infarction (NSTEMI) patients 
at higher risk of in-hospital complications is very important. Such identification will give 
crucial information in determining treatment strategy especially for those come with heart 
failure. One of the simple predictor for short term prognosis in acute coronary syndrome 
is shock index (SI), which is the ratio of heart rate over systolic blood pressure on admis-
sion. There had not been any study conducted to evaluate the use of SI in NSTEMI patients 
come with heart failure. The aim of this study is to evaluate the SI compared with other 
routine clinical and laboratory examination as a predictor of in-hospital major adverse 
cardiac events (MACEs) in NSTEMI patients presenting with heart failure.
Methods: We performed a retrospective analysis of NSTEMI patients with heart failure 
admitted to Haji Adam Malik General Hospital in Medan from January 2014 until July 2015. 
SI was calculated as the ratio of heart rate over systolic blood pressure on presentation. 
Patients presenting with cardiogenic shock were excluded.
Results: There were 55 patients eligible in this study. In-hospital MACEs was found in 24 
patients (44%) compared with 31 patients (56%) without in-hospital MACEs. Patients 
with in-hospital MACEs were older (60.6±10.8 vs. 57.2±7.9, p=0.178), had less his-
tory of dyslipidemia [8(33%) vs. 19 (61%), p=0.032], faster heart rate (111.4±35.8 vs. 
96.5±24.3, p=0.032], higher GRACE score [139(98-187) vs. 120 (91-148); p=0.001], 
and higher SI [0.83(0.57-1.5) vs. 0.67 (0.38-1.27), p=0.013). SI >0.8 was the only inde-
pendent predictor of MACEs in NSTEMI patients presenting with heart failure (OR=4.3, 
CI=1.247-14.328, p=0.048). 
Conclusion: Beyond other routine examinations, SI is the only independent predictor of 
in-hospital MACEs in NSTEMI patients presenting with heart failure.
(Indonesian J Cardiol. 2017;38:81-8)
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Latar Belakang: Identifikasi terjadinya komplikasi selama perawatan pada pasien dengan Infark Miokard Akut Non-elevasi Segmen ST 
(IMANEST) merupakan hal yang sangat penting dilakukan. Hal ini untuk menentukan strategi pengobatan selanjutnya pada kelompok pasien 
ini terutama pada pasien yang tiba dengan kondisi gagal jantung. Salah satu pengukuran terbaru dalam memprediksi kejadian kardiovaskular 
mayor (KKvM) yang sederhana adalah pengukuran indeks syok (IS), yakni pembagian laju denyut jantung terhadap tekanan darah sistolik 
pada saat tiba di rumah sakit. Belum ada penelitian sebelumnya yang menilai manfaat IS dalam memprediksi komplikasi pasien IMANEST 
dengan gagal jantung. Tujuan penelitian ini adalah melihat IS dan membandingkannya dengan pemeriksaan klinis dan laboratorium rutin 
lainnya dalam prediksi terhadap KKvM selama perawatan pada pasien IMANEST dengan gagal jantung.
Metode: Penelitian retrospektif terhadap pasien IMANEST yang tiba di Rumah Sakit Umum Pusat Haji Adam Malik (RSUP HAM) dengan 
kondisi gagal jantung pada periode Januari 2014 hingga Juni 2015. IS dihitung dengan pembagian laju denyut jantung terhadap tekanan darah 
sistolik saat tiba. Pasien dengan syok kardiogenik dieksklusikan. 
Hasil: Terdapat 55 pasien yang memenuhi kriteria inklusi dan eksklusi pada penelitian ini. Pasien dengan KKvM sebanyak 24 orang (44%) dan 
tanpa KKvM 31 orang (56%). Pasien yang mengalami KKvM terlihat lebih tua (60,6±10,8 vs. 57,2±7,9; p=0,178), dengan riwayat dislipidemia 
lebih sedikit [8(33%) vs. 19 (61%), p=0.032], laju denyut nadi lebih cepat  (111,4±35,8 vs. 96,5±24,3; p=0,032], skor GRACE lebih tinggi, 
[139(98-187) vs. 120 (91-148); p=0,001], dan nilai IS lebih tinggi [0,83(0,57-1,5) vs. 0,67 (0,38-1,27); p=0,013). Nilai IS >0,8 merupakan 
prediktor independen satu-satunya terhadap KKVM selama perawatan (OR=4,3; IK=1,247-14,328; p=0,048). 
Kesimpulan: Dibandingkan dengan pemeriksaan rutin lainnya, pemeriksaan IS merupakan prediktor KKvM satu-satunya selama perawatan 
pada pasien IMANEST yang tiba dengan kondisi gagal jantung.
(Indonesian J Cardiol. 2017;38:81-8)
Kata kunci: IMANEST, indeks syok, KKVM
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Introduction
Coronary artery disease (CAD) including acute coronary syndromes (ACS), is the most prevalent manifestation of cardiovascular disease and is associated with 
high mortality and morbidity.1 These are currently the 
leading cause of death in industrialized countries and 
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index (SI).13-16 The SI parameter defined as the ratio of 
heart rate (beats per minute) to systolic blood pressure 
(millimeters of mercury) at admission with the normal 
value range from 0.5-0.7.17 SI will rise in conditions 
where heart rate (HR) increases while the systolic blood 
pressure (SBP) decreases such as hypovolemia and left 
ventricle systolic dysfunction.18
In AMI, there will be myocardial necrosis followed 
by contractility dysfunction that can lead to heart 
failure and cardiogenic shock. Neuro-hormonal 
activation will occur to compensate that occurrence. 
The neuro-hormonal compensation involves the 
sympathetic system, renin-angiotensin-aldosterone 
(RAA) system, and the release of antidiuretic hormone. 
Such compensation reflects in the increasing of HR and 
SBP.19 Over-activity of sympathetic system correlates 
with severity of left ventricle dysfunction.20,21 In the 
pathophysiology view, SI is an integrative parameter 
reflecting hemodynamic conditions of patients.15 
Therefore, SI may be useful in predicting prognosis 
in NSTEMI patients with heart failure.
A few studies have shown that SI is a predictor of 
major adverse cardiac events (MACEs) in ACS, AMI, 
STEMI and NSTEMI. However, there is only one 
study on NSTEMI which performed by Kobayashi 
et al.15 The study showed that SI ≥0.7 had higher 
in-hospital mortality, higher cardiogenic shock at 
admission and lower left ventricle ejection fraction 
(LVEF).15
SI seems to be a simple but very useful tool in 
predicting AMI complications. This examination can 
be performed in situations where laboratory value 
cannot be obtained. SI also can be used as a bedside 
tool in daily practice. Hence, this examination is very 
useful in developing countries such as Indonesia.
The aim of this study is to evaluate the SI compared 
with other routine clinical and laboratory examination 
as a predictor of in-hospital major adverse cardiac 
events (MACEs) in NSTEMI patients presenting with 
heart failure.
Methods
This is a retrospective study of NSTEMI patients 
who were treated at the National General Hospital 
Adam Malik from January 2014 to July 2015. Subjects 
are patients with NSTEMI diagnosis based on the 
criteria from Indonesian Heart Association (IHA) 
with complaints of acute angina pectoris without 
are expected to become so in emerging countries by 
2020.1,2
Non-ST Elevation Myocardial Infarction (NSTEMI) 
patients appear to have lower short-term mortality 
compared with ST Elevation Myocardial Infarction 
(STEMI) individuals, but both have similar outcomes 
in a long term.3 NSTEMI patients have differences in 
baseline characteristics, including older age and a greater 
prevalence of co-morbidities.3-6 The clinical spectrum of 
non-ST-elevation ACS (NSTE-ACS) may range from 
patients free of symptoms at presentation to individuals 
with ongoing ischemia, heart failure, electrical or 
hemodynamic instability or cardiac arrest.3 These 
wide clinical spectrum of NSTEMI require physician 
to perform good risk stratification. Given that risk 
stratification is a starting point in determining whether 
a patient with NSTEMI will undergo an invasive or 
conservative strategy, attempts to improve predictive 
ability of the patient outcome are essential.
Currently, Global Registry of Acute Coronary 
Events (GRACE) score is the most accurate score for 
predicting both short-term and long-term risks.7,8 
Eight parameters are used for calculating GRACE score 
that include patient’s age, heart rate, systolic blood 
pressure, Killip class, serum creatinine level, cardiac 
arrest at hospital admission, ST-segment deviation 
in ECG and elevated cardiac marker.9 This score are 
sophisticated and one must calculate this score using 
smartphone, tablet or laptop.10
NSTEMI patients can present with stable 
conditions, heart failure, or cardiogenic shock. 
Patients with Killip class II and III (heart failure) 
and  IV (cardiogenic shock) made up 11% of the 
population but accounted for 30% of the deaths.11 
In Killip IV mortality is high (67%) and guidelines 
had specific mandates for physician to perform early 
invasive strategy.3 In Killip II-III, mortality is ranging 
from 17%-38% and risk stratification must be done 
accurately.11 Data from the GRACE registry shows 
13% of ACS patients had an admission diagnosis of 
heart failure (Killip class II or III). Heart failure (HF) 
on admission was associated with a marked increase in 
mortality rates during hospitalization and at 6 months 
after discharge.12
In the GRACE score, the Killip class is one of the 
components of the score. This becomes the limitation 
of the GRACE score to predict the complication other 
than mortality in Killip class II, III, and IV. 
One of the emerging and simple predictor of 
cardiovascular complications in ACS is the shock 
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ST segment elevation persistent in two contiguous 
leads with significant increasing cardiac enzymes22 
and presenting signs defined in Killip II and/or III 
classification. Killip Class II describes individuals with 
findings of mild to moderate heart failure (S3 gallop, 
rales below half-way up lung fields or elevated jugular 
venous pressure). Killip Class III describes individuals 
with occurrence of pulmonary edema.
Exclusion criteria in this study are patients with 
cardiogenic shock, severe bradycardia resulting from 
2nd-3rd degree AV block, left branch bundle block 
(LBBB) when an unknown previous ECG and patients 
with severe comorbidities at admission i.e. sepsis, severe 
exacerbating chronic obstructive pulmonary disease 
(COPD), acute renal failure requiring emergency 
hemodialysis, and acute stroke that could influence 
the occurrence of major adverse cardiac events 
(MACEs).
The MACEs is defined for all-cause mortality and 
cardiogenic shock in all of the patients. In patients with 
Killip II, MACEs is defined by previously mentioned 
criteria plus the occurrence of acute pulmonary edema 
during hospitalization. 
According to the formula for computing sample 
size for categorical analysis in independent samples, 
we found the minimal number of samples is 21 for 
each group. Our samples were collected from January 
2014 until July 2015. 
SI was calculated as the ratio of HR/SBP on 
admission. We used the cut-off value of 0.8 based on 
the previous study.13
We searched the medical records of NSTEMI 
patients with Killip II and III in this periode and di-
vided them into groups of patients with MACEs and 
without MACEs. Confounding variables were also 
noted, including age, gender, risk factors for coronary 
heart disease (hypertension, diabetes, hypercholester-
olemia, smoking, and age), blood pressure, heart rate, 
Killip class, routine laboratory findings (complete 
blood count, renal function, electrolytes, initial blood 
glucose, and cardiac enzymes), arrhythmias, treatment 
and medication for the patients. We noted the clinical 
course of patients during treatment to see in-hospital 
MACEs afterward.
Statistical Analysis
Significant statistical difference was defined as p 
value <0.05. Categorical variables were presented 
with the number or frequency (n) and percentage 
(%). Numerical variables were presented with a 
mean (average) and standard deviation for normally 
distributed data, and using median if the data were 
not normally distributed. Normality test was done 
using one sample Kolmogorov-Smirnov (n >50) or 
the Shapiro Wilk (n <50). Normally distributed data 
were analyzed with two independent-samples T-Test 
and Mann Whitney U test for the data that were 
not normally distributed. Categorical variables were 
analyzed using chi square or Fisher tests. Variables 
found to be significant on bivariate analysis test were 
continued into multivariate analysis with logistic 
regression test. 
Results
During the period from January 2014 to July 2015 there 
were 60 patients admitted with a diagnosis of NSTEMI 
dan HF (Killip II and III). From these 60 patients, 55 
patients met the inclusion and exclusion criteria. 
Baseline characteristics are shown in Table 
1. Subjects are divided into two groups based on 
occurrence of MACEs. The groups with MACEs 
were older, more in Killip III conditions, but were 
not significantly different. In this study, patients with 
in-hospital MACEs had faster heart rate (111.4±35.8 
vs. 96.5±24.3, p=0.032), fewer history of dyslipidemia 
[8 (33%) vs. 19(61%), p=0.040], higher shock index 
[0.83 (0.57-1.5) vs. 0.67 (0.38-1.27), p=0.013], and 
higher GRACE score [139 (98-187) vs. 120 (91-
148), p=0.001)]. There were no statistical significant 
differences in laboratory examination and other CAD 
risk factor beside history of dyslipidemia. 
MACEs occurred in 24 patients. All-cause mortal-
ity found in 11 patients (20%), CS in 5 patients (9%), 
and acute pulmonary edema in 8 patients (15%). 
From the bivariate analysis, we found two variables 
that had significant differences, which was SI >0.8 
and history of dyslipidemia. We include 5 variables 
that had p value <0.25 (history of hypertension, GFR 
<30 mL/min/1.73 m2, GRACE score >140. Killip 
class III, and Chloride level <97) plus one variable 
HR>100 bpm from author consideration based on 
previous study.23 These eight variables then entered 
into multivariate analysis. The results showed shock 
index >0.8 become the independent predictor of 
MACEs from the multivariate analysis [OR 4.226 
(1.247-14.328); p=0.021]. 
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Table 1. Baseline characteristics.
Overall
n=55
In-hospital MACE (+)
n=24 (44%)
In-hospital MACE (-)
n=31 (56%)
p value
Age (years) 58.7±9.3 60.6±10.8 57.2±7.9 0.178*
Sex (male) 40 (73%) 19 (79%) 21 (68%) 0.345**
Body Mass Index (BMI) 24.5 (20.3-35) 24.4 (20.8-35.2) 24.5 (20.3-32) 0.905***
Risk factor
Hypertension 41 (75%) 16 (67%) 25 (81%) 0.238**
Diabetes 24 (43%) 10 (42%) 14 (45%) 0.796**
Dyslipidemia 27 (49%) 8 (33%) 19 (61%) 0.040**
Smoker 36 (66%) 15 (63%) 21 (68%) 0.685**
Hemodynamic conditions
Systolic BP 134.7±29.0 131.3±32.7 137.4±25.9 0.439*
Diastolic BP 80 (50-130) 80 (60-120) 80 (50-130) 0.661***
Heart rate 102.9±25.8 111.4±25.8 96.5±24.3 0.032*
Atrial Fibrillation (n, %) 3 (5%) 3 (12.5%) 0 (0%) 0.077**
Shock Index 0.75 (0.38-1.5) 0.83 (0.57-1.5) 0.67 (0.38-1.27) 0.013***
SI >0.8 20 (36%) 13 (54%) 7 (23%) 0.016**
Killip Class III 17 (31%) 10 (42%) 7 (23%) 0.129**
Presenting with infection 14 (25.5%) 8 (33.3%) 6 (19.4%) 0.238**
Laboratory findings 
Hemoglobin (mg/dl) 12.8±2.2 12.7±1.9 12.9±2.4 0.627*
Leucocyte (/mm3) 12110 (6280-33990) 11765 (6280-26500) 13782 (6320-33990) 0.879***
Admission blood glucose level (mg/
dl)
141 (59-708) 160 (70-708) 138 (59-423) 0.290***
Ureum (mg/dl) 55.1 (15-345) 53.6 (15-260) 56.8 (21.9-345) 0.728***
Creatinine (mg/dl) 1.5 (0.6-12) 1.54 (0.69-12) 1.4 (0.6-8.4) 0.435***
GFR (mL/min/1.73 m2) 47.8±24.6 44.9±27.3 49.6±22.9 0.546*
GFR <30 mL/min/1.73 m2 13 (23%) 8 (33%) 5 (16%) 0.136**
Natrium (mEq) 136 (118-145) 134±7.1 136±4.6 0.225*
Potassium (mEq) 4.1 (2.6-6) 4.1 (3.2-6) 4.1 (2.6-6.2) 0.363***
Chloride (mEq) 105 (86-111) 103 (86-110) 105 (94-114) 0.104***
Troponin T (ng/ml) 0.45 (0.1-2) 0.58 (0.11-2) 0.37 (0.1-2) 0.257***
Osmolality (osm/L) 290.3 (255.2-353.3) 291±15 292±13 0.557*
GRACE score 131.3±22.9 139 (98-187) 120 (91-148) 0.001***
GRACE risk score >140 21 (38%) 12 (50%) 9 (29%) 0.112**
In-hospital medication and treatment
Diuretics 55 (100%) 24 (44%) 31 (56%) NS
ACE-inhibitors or ARBs 36 (65.4%) 15 (62.5%) 21 (67.8%) 0.685**
Beta blockers 31 (56.3%) 13 (54.2%) 18 (58.1%) 0.773**
Double antiplatelet 51 (92.7%) 21 (87.5%) 30 (96.7%) 0.307**
Anticoagulant 51 (92.7%) 21 (87.5%) 30 (96.7%) 0.307**
Coronary Angiography 17 (30.9%) 6 (25%) 11 (35.5%) 0.404**
Angiography Result 
3VD and/or LM
2 VD
1 VD
14 (25.4%)
-
3 (5.5%)
6 (25%)
-
-
8 (25.8%)
-
3 (9.7%)
NS**
Revascularization 3 1 2 NS**
* Independent T-Test 
**Chi Square 
***Mann Whitney
 86
Indonesian Journal of Cardiology 
Indonesian J Cardiol •  Vol. 38, Issue 2 • April - June 2017
Discussions
In this study, patients with in-hospital MACEs had 
faster heart rate (111.4±35.8 vs. 96.5±24.3, p=0.032). 
This is the same result with the previous study.23 This 
founding suggest that in HF patients, neuro-hormonal 
compensation as reflected by HR can reflect the clinical 
severity of the patients thus the complication and 
outcome. 
Many factors can affect heart rate and/or blood 
pressure and as well as the shock index. The factors 
such as previous medication that lowering heart rate 
(eg. beta blocker, digoxin, and non-dihydropyridine), 
AV block, treatment on antihypertension, and condi-
tion such as infection and hypovolemia. From the 
medical records, we did not find complete and specific 
notes about previous medication so we cannot put 
this on the current analysis. As we mentioned above 
that sepsis patients and severe AV block at admission 
were excluded so these would not affect our analysis 
on shock index. There were 9 patients suffered from 
infection, namely pneumonia (8 patients) and lung 
tuberculosis (1 patient). However, these condition 
did not give statistical differences on shock index 
(p=0.261). There were no patients in hypovolemic 
state requiring rehydration at admission.
Both SBP and DBP (diastolic blood pressure) did 
not differ significantly. This finding seems contrary 
with the results of Bangalore et al study which found 
the paradox of blood pressure (BP) in predicting mor-
tality in NSTE-ACS.24 There are few differences in 
our study which exclude the unstable angina pectoris 
(UAP) patients, Killip I and IV NSTEMI patients. 
This finding suggests that in NSTEMI patients pre-
senting with heart failure, BP alone cannot predict the 
outcome of patients. 
From the study of Kobayashi et al15 patients 
with SI ≥0.7 had a lower LVEF, higher rate of car-
diogenic shock on admission, and higher in-hospital 
mortality. The study did not specify the patients. Our 
study specify the patients into the NSTEMI with HF 
condition. Our study showed that SI >0.8 was the 
only independent predictor of MACEs. From the 
statistical analysis, SI is better than BP and HR alone. 
This finding suggested the role of SI as an integrative 
hemodynamic parameter.
In this study, Killip class III did not show differ-
ences in predicting mortality. This finding is important 
that between patients in Killip II and III, physician 
still should be aware of the risk of complications in 
both group.
Other factors can affect the occurrence of MACEs 
such as arrhythmias and in-hospital treatment. There 
were 3 patients presenting with atrial fibrillation and 
none with neither supraventricular nor ventricular 
arrhythmias. Yet, there were no significant differences 
on MACEs. 
All of the patients received standard medication 
for acute coronary syndrome, including double an-
tiplatelet (DAPT), anticoagulant, and statin. There 
were 3 cases where the DAPT and anticoagulant were 
stopped due to bleeding. The use of angiotensin con-
verting enzyme inhibitor (ACE-i) and or angiotensin 
receptor blocker (ARB) was 65% in all patients, and 
the use of beta blockers (BB) was 56%. When we 
analyzed the influences of medication and treatment 
including revascularization to the MACES, we did not 
found any differences.
Our study showed that patients with in-hospital 
MACEs had higher GRACE score [139 (98-187) vs. 
120 (91-148)] but when divided by the cut-off value 
of 140, it did not show differences. This finding sug-
gests that GRACE score with the validated cut-off 
value cannot be used in predicting complications more 
than just death.
Limitations of study
This was a retrospective study on secondary data with 
Table 2. Bivariate analysis.
OR (CI) p value*
History of Dyslipidemia 0.316 (0.104-0.963) 0.04
History of Hypertension 0.480 (0.140-1.643) 0.238
GFR <30 mL/min/1.73 m2 2.602 (0.723-9.344) 0.136
GRACE >140 2.444 (0.802-7.449) 0.112
Killip Class III 2.449 (0.761-7.885) 0.129
Heart Rate >100 bpm 1.700 (0.579-4.989) 0.333
Chloride <97 mEq 3.816 (0.671-21.715) 0.220
SI >0.8 4.052 (1.266-12.970) 0.016
*Chi Square
Table 3. Multivariate analysis.
OR (CI) p value
SI >0.8 4.226 (1.247-14.328) 0.021
History of Dyslipidemia 0.301 (0.092-0.988) 0.048
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small sample size in single center which became one of 
the limitations of the study. Some of the patients may 
come with previous medication that affects the HR 
such as beta blocker, digoxin, non-dihydropyridine cal-
cium channel blocker and the other antihypertension 
therapy. Unfortunately, in this study we did not have 
complete data about their medication thus we cannot 
see the effect. However, the mean value of HR in this 
study is 102.9 suggesting that all patients maybe were 
in decompensation state of HF. 
Our study found that DBP did not differs sig-
nificantly. Other model of shock index is the modified 
shock index (MSI) which is the ratio of HR/mean arte-
rial pressure (MAP). In this study we did not analyze 
the role of MSI.
Another limitation of this study is that we only 
performed analysis that compares simple routine 
clinical and laboratory examination, as such we did 
not compare with echocardiography parameter such 
as LVEF. We also did not analyze the effect of revas-
cularization for in-hospital MACEs. This was because 
only a small percentage of patients were performed 
coronary angiography (17 patients, 31%).
Conclusion
In this study, beyond other routine examination SI was 
the only independent predictor of in-hospital MACEs 
in NSTEMI patients presenting with heart failure. SI 
is a quick, easy, and cheap way to predict in hospital 
MACEs in NSTEMI patients presenting heart failure 
but requires better research method and design, also 
the bigger sample size before it is ready for primetime 
use. This simple measurement may have important 
and beneficial role in predicting prognosis in remote 
and rural area.
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